(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 28.42 | 42.95 | -33.83 | 131.84 | 143.51 | -8.13 | 131.84 | 143.51 | -8.13 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDT | -1.10 | 1.22 | -190.16 | 4.63 | 5.09 | -9.04 | 4.63 | 5.09 | -9.04 |
| Interest | 0.47 | 1.19 | -60.50 | 0.58 | 1.32 | -56.06 | 0.58 | 1.32 | -56.06 |
| PBDT | -1.57 | 0.03 | -5333.33 | 4.05 | 3.77 | 7.43 | 4.05 | 3.77 | 7.43 |
| Depreciation | 0.19 | 0.18 | 5.56 | 0.77 | 0.76 | 1.32 | 0.77 | 0.76 | 1.32 |
| PBT | -1.76 | -0.15 | 1073.33 | 3.28 | 3.01 | 8.97 | 3.28 | 3.01 | 8.97 |
| TAX | 0.47 | 0.47 | 0.00 | 0.47 | 0.47 | 0.00 | 0.47 | 0.47 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -2.23 | -0.62 | 259.68 | 2.81 | 2.54 | 10.63 | 2.81 | 2.54 | 10.63 |
| Equity | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 |
| PBIDTM(%) | -3.87 | 2.84 | -236.26 | 3.51 | 3.55 | -0.99 | 3.51 | 3.55 | -0.99 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: